16-61654097-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The ENST00000577390.6(CDH8):c.1911C>T(p.Ile637=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,608,788 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0057 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00058 ( 14 hom. )
Consequence
CDH8
ENST00000577390.6 synonymous
ENST00000577390.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0240
Genes affected
CDH8 (HGNC:1767): (cadherin 8) This gene encodes a type II classical cadherin from the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Mature cadherin proteins are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. The extracellular domain consists of 5 subdomains, each containing a cadherin motif, and appears to determine the specificity of the protein's homophilic cell adhesion activity. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. This particular cadherin is expressed in brain and is putatively involved in synaptic adhesion, axon outgrowth and guidance. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 16-61654097-G-A is Benign according to our data. Variant chr16-61654097-G-A is described in ClinVar as [Benign]. Clinvar id is 711179.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.024 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00568 (864/152156) while in subpopulation AFR AF= 0.0198 (820/41514). AF 95% confidence interval is 0.0186. There are 9 homozygotes in gnomad4. There are 409 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 864 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH8 | NM_001796.5 | c.1911C>T | p.Ile637= | synonymous_variant | 12/12 | ENST00000577390.6 | NP_001787.2 | |
CDH8 | XM_005255760.5 | c.1911C>T | p.Ile637= | synonymous_variant | 12/13 | XP_005255817.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH8 | ENST00000577390.6 | c.1911C>T | p.Ile637= | synonymous_variant | 12/12 | 1 | NM_001796.5 | ENSP00000462701 | P1 | |
CDH8 | ENST00000299345.10 | c.1911C>T | p.Ile637= | synonymous_variant | 12/13 | 5 | ENSP00000299345 | |||
CDH8 | ENST00000577730.5 | c.1911C>T | p.Ile637= | synonymous_variant | 11/12 | 5 | ENSP00000462018 | |||
CDH8 | ENST00000585315.5 | c.*358C>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/11 | 5 | ENSP00000463266 |
Frequencies
GnomAD3 genomes AF: 0.00566 AC: 861AN: 152038Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
861
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00138 AC: 342AN: 247436Hom.: 3 AF XY: 0.000969 AC XY: 130AN XY: 134122
GnomAD3 exomes
AF:
AC:
342
AN:
247436
Hom.:
AF XY:
AC XY:
130
AN XY:
134122
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000583 AC: 849AN: 1456632Hom.: 14 Cov.: 32 AF XY: 0.000512 AC XY: 371AN XY: 724302
GnomAD4 exome
AF:
AC:
849
AN:
1456632
Hom.:
Cov.:
32
AF XY:
AC XY:
371
AN XY:
724302
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00568 AC: 864AN: 152156Hom.: 9 Cov.: 32 AF XY: 0.00550 AC XY: 409AN XY: 74368
GnomAD4 genome
AF:
AC:
864
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
409
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at